Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

The damage can lead to both sudden “flares” of inflammation and a slow worsening of symptoms over time. Historically, MS has been broken down into specific subtypes, as detailed below. But the reality ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib ...

Request To Download Free Sample of This Strategic Report @ The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of ...

Roche’s fenebrutinib shows unprecedented positive phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

Lupus has been linked to the Epstein-Barr virus – which causes glandular fever, or mono – before, but we now have evidence of ...

Clay Walker has been battling multiple sclerosis (MS) since 1996, and he’s had ups and downs with the disease over the years.

New research from Stanford University links the Epstein-Barr virus to lupus disease, showing how the virus can push immune ...